Tong-Ho Lin

Title: Innovations of Inventor Tong-Ho Lin

Introduction

Tong-Ho Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in formulations that address critical health issues. With a total of 6 patents, his work has the potential to impact the treatment of opioid use disorder and other central nervous system diseases.

Latest Patents

One of his latest patents is the "Naltrexone injectable sustained release formulation." This innovative formulation includes 3-acyl-naltrexone or a pharmaceutically acceptable salt, a biocompatible organic solvent, and optionally a biocompatible polymeric material. The method aims to treat opioid use disorder or alcoholism by administering the injectable formulation, which provides a sustained release profile after a single injection. In studies with minipigs, the plasma levels of naltrexone demonstrated a sustained release for up to two months.

Another significant patent is related to "Ketamine pamoate and use thereof." This patent involves pamoate salts of ketamine with a stoichiometry of 2:1 of ketamine to pamoate. It includes various forms of the pamoate salts, which exhibit excellent safety and properties for pharmaceutical applications. The patent also covers pharmaceutical compositions that utilize these pamoate salts in treating CNS diseases or as anesthetics.

Career Highlights

Throughout his career, Tong-Ho Lin has worked with Alar Pharmaceuticals, Inc., where he has contributed to the development of innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Tong-Ho Lin has collaborated with notable professionals in his field, including Yung-Shun Wen and Jui-Wei Liang. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.

Conclusion

Tong-Ho Lin's contributions to pharmaceutical formulations demonstrate his commitment to addressing significant health challenges. His innovative patents reflect a deep understanding of drug delivery systems and their potential impact on patient care.